<SEC-DOCUMENT>0000902664-23-001677-index.html : 20230214
<SEC-HEADER>0000902664-23-001677.hdr.sgml : 20230214
<ACCEPTANCE-DATETIME>20230214093553
ACCESSION NUMBER:		0000902664-23-001677
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230214
DATE AS OF CHANGE:		20230214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acrivon Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001781174
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				825125532
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93824
		FILM NUMBER:		23623492

	BUSINESS ADDRESS:	
		STREET 1:		480 ARSENAL WAY, SUITE 100
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-207-8979

	MAIL ADDRESS:	
		STREET 1:		480 ARSENAL WAY, SUITE 100
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Marshall Wace North America L.P.
		CENTRAL INDEX KEY:			0001325091
		IRS NUMBER:				470943020
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		C/O MARSHALL WACE NORTH AMERICA L.P.
		STREET 2:		350 PARK AVE., 18TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		212-235-2800

	MAIL ADDRESS:	
		STREET 1:		C/O MARSHALL WACE NORTH AMERICA L.P.
		STREET 2:		350 PARK AVE., 18TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Marshall Wace North America, L.P.
		DATE OF NAME CHANGE:	20050518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Marshall Wace North America L.P.
		DATE OF NAME CHANGE:	20050426
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>p23-0196sc13g.htm
<DESCRIPTION>ACRIVON THERAPEUTICS, INC.
<TEXT>
Document 1 - file: p23-0196sc13g.htm

</DOCUMENT>
</SEC-DOCUMENT>